Previous close | 1.7650 |
Open | 1.8100 |
Bid | 1.3200 x 200 |
Ask | 2.2700 x 200 |
Day's range | 1.7600 - 1.8300 |
52-week range | 1.1600 - 3.4500 |
Volume | |
Avg. volume | 347,658 |
Market cap | 142.354M |
Beta (5Y monthly) | 1.11 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Q1 2024 Summit Therapeutics Inc Earnings Call
I-Mab ( NASDAQ:IMAB ) Full Year 2023 Results Key Financial Results Net loss: CN¥1.47b (loss narrowed by 39% from FY...
Q4 2023 Summit Therapeutics Inc Earnings Call